Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

Clinical trial NCT02285101 · COMPLETED

Trial details

NCT number: NCT02285101
Sponsor: Bio-Cancer Treatment International Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Prostate Adenocarcinoma

Start date: 2014-11-01
Primary completion: 2019-02-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.